Cargando…

A Correlate of HIV-1 Control Consisting of Both Innate and Adaptive Immune Parameters Best Predicts Viral Load by Multivariable Analysis in HIV-1 Infected Viremic Controllers and Chronically-Infected Non-Controllers

HIV-1 infected viremic controllers maintain durable viral suppression below 2000 copies viral RNA/ml without anti-retroviral therapy (ART), and the immunological factor(s) associated with host control in presence of low but detectable viral replication are of considerable interest. Here, we utilized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomescu, Costin, Liu, Qin, Ross, Brian N., Yin, Xiangfan, Lynn, Kenneth, Mounzer, Karam C., Kostman, Jay R., Montaner, Luis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117509/ https://www.ncbi.nlm.nih.gov/pubmed/25078947 http://dx.doi.org/10.1371/journal.pone.0103209

Ejemplares similares

Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection
por: Papasavvas, Emmanouil, et al.
Publicado: (2004)

Elite and viremic HIV-1 controllers in West Africa
por: N’takpé, Jean Baptiste, et al.
Publicado: (2022)

Sustained Viremic Control in HIV-Infected Patient: Case Report from Nepal
por: Khadka, Sundar, et al.
Publicado: (2018)

Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers
por: Gonzalo-Gil, Elena, et al.
Publicado: (2017)

Interferon-α alters host glycosylation machinery during treated HIV infection
por: Giron, Leila B., et al.
Publicado: (2020)

Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV
por: Giron, Leila B., et al.
Publicado: (2021)

Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load
por: Grant-McAuley, Wendy, et al.
Publicado: (2023)

Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses
por: Salgado, Maria, et al.
Publicado: (2018)

Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors
por: Egaña-Gorroño, Lander, et al.
Publicado: (2014)

Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection
por: Singh, Amit Kumar, et al.
Publicado: (2020)

Low levels of anti-MPER antibodies are detectable in viremic HIV infected
por: Carrillo, J, et al.
Publicado: (2012)

Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and art-suppressed individuals
por: Caetano, Diogo Gama, et al.
Publicado: (2022)

Viremic long-term nonprogressive HIV-1 infection is not associated with abnormalities in known Nef functions
por: Heigele, Anke, et al.
Publicado: (2014)

Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
por: Giron, Leila B., et al.
Publicado: (2021)

The Role of Innate Immunity in Natural Elite Controllers of HIV-1 Infection
por: Shi, Yuting, et al.
Publicado: (2022)

Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
por: Lorin, Valérie, et al.
Publicado: (2022)

Different Immunological Phenotypes Associated with Preserved CD4+ T Cell Counts in HIV-Infected Controllers and Viremic Long Term Non-Progressors
por: Gaardbo, Julie Christine, et al.
Publicado: (2013)

Decreased Mutation Frequencies among Immunoglobulin G Variable Region Genes during Viremic HIV-1 Infection
por: Bowers, Elisabeth, et al.
Publicado: (2014)

Constitutive Gene Expression in Monocytes from Chronic HIV-1 Infection Overlaps with Acute Toll-Like Receptor Induced Monocyte Activation Profiles
por: Gekonge, Bethsebah, et al.
Publicado: (2012)

645 Structural Bone Deficits in HIV/HCV, HCV-Monoinfected, and HIV-Monoinfected Women
por: Lo Re, Vincent, et al.
Publicado: (2014)

1610 Pervasive B cell Activation during Viremic HIV-1 Infection but Effective Responses with Appropriate Stimulation in vitro
por: Nicholson, Lindsay, et al.
Publicado: (2014)

HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy
por: Omondi, F. Harrison, et al.
Publicado: (2021)

HIV-1 DNA Testing in Viremic Patients Identifies More Drug Resistance Than HIV-1 RNA Testing
por: Curanovic, Dusica, et al.
Publicado: (2023)

Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals
por: Moir, Susan, et al.
Publicado: (2008)

Robust HIV-specific CD4(+) and CD8(+) T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors
por: Vieira, Vinicius A., et al.
Publicado: (2022)

Brief Report: Identification of Elite and Viremic Controllers From a Large Urban HIV Ambulatory Center in Kampala, Uganda
por: Kayongo, Alex, et al.
Publicado: (2018)

A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects
por: Brown, Jennifer, et al.
Publicado: (2014)

Safety and anti-viral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
por: Bar-On, Yotam, et al.
Publicado: (2018)

Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors
por: Colomer-Lluch, Marta, et al.
Publicado: (2022)

Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity
por: Ruiz, María Julia, et al.
Publicado: (2015)

Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County
por: Gahrton, Caroline, et al.
Publicado: (2019)

HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic
por: Cabrera-Rodríguez, Romina, et al.
Publicado: (2019)

FcRL4 Expression Identifies a Pro-inflammatory B Cell Subset in Viremic HIV-Infected Subjects
por: Siewe, Basile, et al.
Publicado: (2017)

Innate Antiviral Response: Role in HIV-1 Infection
por: Pitha, Paula M.
Publicado: (2011)

Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients
por: Witwer, Kenneth W, et al.
Publicado: (2012)

Editorial: Innate immune responses in HIV controllers
por: Thobakgale, Christina, et al.
Publicado: (2023)

959. HIV-1 DNA Testing Identifies Drug Resistance in Viremic Patients with Pan-Sensitive Plasma Virus
por: Curanovic, Dusica, et al.
Publicado: (2020)

Infection control since HIV
por: Croser, David
Publicado: (2020)

Limited HIV Infection of Central Memory and Stem Cell Memory CD4+ T Cells Is Associated with Lack of Progression in Viremic Individuals
por: Klatt, Nichole R., et al.
Publicado: (2014)

The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infection
por: Noto, Alessandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1d1eq7s9smpbsii5k99s4sr83n